Mater Private Network is expanding its radiotherapy service in Limerick, giving public and private cancer patients across the Mid-West access to a broader range of specialist expertise and…
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Gilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.
Beacon Hospital has treated the first patient in Ireland and the UK using RapidArc Dynamic radiotherapy technology. Delivered through the Varian TrueBeam system, the platform offers exceptional precision, faster planning and treatment times, and greater protection of healthy tissue in cancer care.
